Company profile: Kerecis
1.1 - Company Overview
Company description
- Provider of patented fish-skin and fatty acid-based products for cellular therapy, regenerative medicine, and wound/surgical care, including Kerecis Omega3 Wound, Omega3 SurgiClose, Omega3 SurgiBind, Omega3 GraftGuide, WOUND spray, and 1 Primary Wound Dressing spray; gently processed fish skin retains human skin-like structure with no disease-transfer risk from cold-water fish.
Products and services
- Kerecis Omega3 GraftGuide: Patented fish-skin component guides grafting in surgical and wound care, retaining human-skin similarity from gentle processing and eliminating fish-to-human disease transfer
- Kerecis Omega3 SurgiClose: Cold-water-fish-derived fish skin product engineered for surgical wound closure, preserving human-skin-like architecture from gentle processing to aid healing with no disease-transfer risk
- Kerecis Omega3 Wound: Omega3-rich fish skin assembly produced for wound treatment, retaining human-skin similarity through minimal processing and avoiding fish-to-human disease-transfer risk to support regenerative healing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kerecis
Humacyte
HQ: United States
Website
- Description: Provider of bioengineered vascular and anatomical conduit solutions, including the Human Acellular Vessel (HAV) in clinical trials for trauma repair and arteriovenous access; the LUNA200 bioengineering system for producing HAV; and the BioVascular Pancreas in preclinical studies for type 1 diabetes, delivering insulin-producing islets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Humacyte company profile →
Nerites
HQ: United States
Website
- Description: Provider of synthetic biomaterials designed to enhance natural tissue repair, reduce complications from traditional devices, and safely degrade when no longer needed.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nerites company profile →
Meccellis Biotech
HQ: France
Website
- Description: Provider of biomaterials and tissue and cell engineering, creating biological implants in dialogue with surgeons. Products include CELLIS, a preservative-free dermal matrix for varied surgeries; CELLIS Breast, a porcine dermis matrix for breast reconstruction; and CELLIS Dental, a non-pyrogenic acellular membrane for dental soft tissue repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meccellis Biotech company profile →
Cutiss
HQ: Switzerland
Website
- Description: Provider of regenerative medicine and skin tissue engineering solutions, including denovoSkin, a personalized bio-engineered skin graft for permanent treatment of skin defects and injuries; Viticell, a CE-marked cell therapy for vitiligo and dyspigmented burn scars; automated manufacturing of tissue therapies, clinical development programs, and named-patient basis treatment options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cutiss company profile →
BioD Logics
HQ: United States
Website
- Description: Provider of novel biologic products derived from placental tissues, engaged in the development and commercialization of biologics and focused on research into the regenerative potential of amnion and other placental tissues; a vertically integrated biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioD Logics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kerecis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kerecis
2.2 - Growth funds investing in similar companies to Kerecis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kerecis
4.2 - Public trading comparable groups for Kerecis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →